Psychedelic DMT trial aims to curb alcohol addiction
NCT ID NCT06070649
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study tests whether the psychedelic drug DMT, combined with psychotherapy, can help people with alcohol use disorder. 63 participants will receive either a moderate or low dose of DMT, or a placebo, and their safety and desire to drink will be measured. The goal is to see if the psychedelic experience can reduce alcohol consumption.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DMT (dimethyltryptamine), a psychedelic drug
What this could lead to
If it works, this could point toward a new treatment option for alcohol use disorder that combines a psychedelic experience with therapy.
What could go wrong
This is a very early Phase 1 trial with only 63 people, focused on safety. It is too soon to know if DMT actually helps reduce drinking, and psychedelics can cause intense psychological reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER (AUD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Connecticut Mental Health Center
RECRUITINGNew Haven, Connecticut, 06519, United States
Contact Email: •••••@•••••
Contact